1. Home
  2. LXRX vs IIIN Comparison

LXRX vs IIIN Comparison

Compare LXRX & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • IIIN
  • Stock Information
  • Founded
  • LXRX 1995
  • IIIN 1953
  • Country
  • LXRX United States
  • IIIN United States
  • Employees
  • LXRX N/A
  • IIIN N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • IIIN Steel/Iron Ore
  • Sector
  • LXRX Health Care
  • IIIN Industrials
  • Exchange
  • LXRX Nasdaq
  • IIIN Nasdaq
  • Market Cap
  • LXRX 650.7M
  • IIIN 587.8M
  • IPO Year
  • LXRX 2000
  • IIIN N/A
  • Fundamental
  • Price
  • LXRX $0.98
  • IIIN $30.14
  • Analyst Decision
  • LXRX Buy
  • IIIN
  • Analyst Count
  • LXRX 2
  • IIIN 0
  • Target Price
  • LXRX $6.00
  • IIIN N/A
  • AVG Volume (30 Days)
  • LXRX 4.3M
  • IIIN 124.0K
  • Earning Date
  • LXRX 11-12-2024
  • IIIN 10-17-2024
  • Dividend Yield
  • LXRX N/A
  • IIIN 0.40%
  • EPS Growth
  • LXRX N/A
  • IIIN N/A
  • EPS
  • LXRX N/A
  • IIIN 0.99
  • Revenue
  • LXRX $5,229,000.00
  • IIIN $529,198,000.00
  • Revenue This Year
  • LXRX $1,212.46
  • IIIN $9.60
  • Revenue Next Year
  • LXRX $219.10
  • IIIN $16.98
  • P/E Ratio
  • LXRX N/A
  • IIIN $30.44
  • Revenue Growth
  • LXRX 886.60
  • IIIN N/A
  • 52 Week Low
  • LXRX $0.97
  • IIIN $26.74
  • 52 Week High
  • LXRX $3.73
  • IIIN $39.38
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 25.78
  • IIIN 57.20
  • Support Level
  • LXRX $1.01
  • IIIN $29.82
  • Resistance Level
  • LXRX $1.35
  • IIIN $30.50
  • Average True Range (ATR)
  • LXRX 0.12
  • IIIN 0.66
  • MACD
  • LXRX -0.06
  • IIIN 0.35
  • Stochastic Oscillator
  • LXRX 0.43
  • IIIN 85.71

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About IIIN Insteel Industries Inc.

Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.

Share on Social Networks: